Control of postprandial hyperglycemia by oral administration of the sea anemone mucus-derived α-amylase inhibitor (magnificamide)

Control of postprandial hyperglycemia by oral administration of the sea anemone mucus-derived α-amylase inhibitor (magnificamide)

Diabetes mellitus is a serious threat to human health in both developed and developing countries. Optimal disease control requires the use of a diet and a combination of several medications, including oral hypoglycemic agents such as α-glucosidase inhibitors. Currently, the arsenal of available drug...

Full description

Bibliographic Details
Main Authors: Oksana Sintsova, Darya Popkova, Aleksandr Kalinovskii, Anton Rasin, Natalya Borozdina, Elvira Shaykhutdinova, Anna Klimovich, Alexander Menshov, Natalia Kim, Stanislav Anastyuk, Mikhail Kusaykin, Igor Dyachenko, Irina Gladkikh, Elena Leychenko
Format: Article
Language:English
Published: Elsevier 2023-12-01
Series:Biomedicine & Pharmacotherapy
Subjects:
Hyperglycemia
α-amylase inhibitor
Diabetes
Metabolism
Sea anemone
Venom
Online Access:http://www.sciencedirect.com/science/article/pii/S075333222301541X

Internet

http://www.sciencedirect.com/science/article/pii/S075333222301541X

Similar Items